Anúncio
Anúncio
ARTV
Artiva Biotherapeutics, Inc. Common Stock
4.85
USDPatrocinado
+0.27
+5.96%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
4.86
0.00
+0.04%
Relatórios de Lucros ARTV
Rácio de surpresa positiva
ARTV separação 3 de 6 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.84
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-4.55%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+27.27%
Artiva Biotherapeutics, Inc. Common Stock earnings per share and revenue
On 12 de nov. de 2025, ARTV reported earnings of -0.88 USD per share (EPS) for Q3 25, beating the estimate of -0.88 USD, resulting in a 0.83% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +10.86% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -0.84 USD, with revenue projected to reach -- USD, implying an diminuir of -4.55% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Artiva Biotherapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Artiva Biotherapeutics, Inc. Common Stock reported EPS of -$0.88, beating estimates by 0.83%, and revenue of $0.00, 0% as expectations.
How did the market react to Artiva Biotherapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 10.86%, changed from $3.59 before the earnings release to $3.98 the day after.
When is Artiva Biotherapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23 de mar. de 2026.
What are the forecasts for Artiva Biotherapeutics, Inc. Common Stock's next earnings report?
Based on 8
analistas, Artiva Biotherapeutics, Inc. Common Stock is expected to report EPS of -$0.84 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio